Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage

scientific article published on 06 June 2006

Efficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.RESUSCITATION.2005.11.008
P698PubMed publication ID16757085

P2093author name stringKathy L Ryan
Edward J Dick
Douglas S Cortez
Anthony E Pusateri
P433issue1
P304page(s)133-144
P577publication date2006-06-06
P1433published inResuscitationQ15753095
P1476titleEfficacy of FDA-approved hemostatic drugs to improve survival and reduce bleeding in rat models of uncontrolled hemorrhage
P478volume70

Reverse relations

cites work (P2860)
Q47324534Biomaterials and Advanced Technologies for Hemostatic Management of Bleeding.
Q38299762Critical care issues in solid organ injury: Review and experience in a tertiary trauma center
Q57465099Effect of ambient particulate matter exposure on hemostasis
Q36752598Effects of different fluid regimes and desmopressin on uncontrolled hemorrhage during hypothermia in the rat.
Q37278074Hemostatic Nanoparticles Improve Survival Following Blunt Trauma Even after 1 Week Incubation at 50 °C.
Q41215308Intravenous hemostatic nanoparticles increase survival following blunt trauma injury
Q38148673Intravenous hemostats: challenges in translation to patients
Q60049219Tranexamic acid decreases rodent hemorrhagic shock-induced inflammation with mixed end-organ effects
Q42579276Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma